Changes of costimulatory molecule CD28 on circulating CD8+ T cells correlate with disease pathogenesis of chronic hepatitis B

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Li, Xuefen ^a,b   Kong, Haishen ^a   Tian, Li ^b   Zhu, Qiaoyun ^b   Wang, Yiyin ^b   Dong, Yuejiao ^b   Ni, Qin ^a   Chen, Yu ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; HEPATITIS B(E) ANTIGEN; PEGINTERFERON ALPHA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD8+ CD28+ T CELL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROSPECTIVE STUDY; T LYMPHOCYTE SUBPOPULATION; VIREMIA; BLOOD; CELL LINEAGE; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY;

ADULT; ANTIGENS, CD28; CD8-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LONGITUDINAL STUDIES; MALE;

EID: 84903641506     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/423181     Document Type: Article

References (18)

1. Hilleman M. R., Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 2003 21 32 4626 4649 2-s2.0-0142227000 10.1016/S0264-410X(03)00529-2 (Pubitemid 37329857)
2. Wang F.-S., Zhang Z., Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus. Expert Review of Gastroenterology and Hepatology 2009 3 5 499 512 2-s2.0-70449724811 10.1586/egh.09.50
3. Chisari F. V., Isogawa M., Wieland S. F., Pathogenesis of hepatitis B virus infection. Pathologie Biologie 2010 58 4 258 266 2-s2.0-77955432247 10.1016/j.patbio.2009.11.001
4. Boni C., Laccabue D., Lampertico P., Giuberti T., Viganò M., Schivazappa S., Alfieri A., Pesci M., Gaeta G. B., Brancaccio G., Colombo M., Missale G., Ferrari C., Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Gastroenterology 2012 143 4 963 e9 2-s2.0-84866705034 10.1053/j.gastro.2012.07.014
5. Lau G. K. K., Cooksley H., Ribeiro R. M., Powers K. A., Shudo E., Bowden S., Hui C.-K., Anderson J., Sorbel J., Mondou E., Rousseau F., Lewin S., Perelson A. S., Locarnini S., Naoumov N. V., Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B. Antiviral Therapy 2007 12 5 705 718 2-s2.0-34547768137 (Pubitemid 47235485)
6. Boćko D., Kosmaczewska A., Ciszak L., Teodorowska R., Frydecka I., CD28 costimulatory molecule-expression, structure and function. Archivum Immunologiae et Therapiae Experimentalis 2002 50 3 169 177 2-s2.0-0036052441
7. Shearer W. T., Rosenblatt H. M., Gelman R. S., Oyomopito R., Plaeger S., Stiehm E. R., Wara D. W., Douglas S. D., Luzuriaga K., McFarland E. J., Yogev R., Rathore M. H., Levy W., Graham B. L., Spector S. A., Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. Journal of Allergy and Clinical Immunology 2003 112 5 973 980 2-s2.0-0242550686 10.1016/j.jaci.2003.07.003 (Pubitemid 37412068)
8. - T lymphocytes is vital for patients with ulcerative colitis. Digestive Diseases and Sciences 2013 58 1 88 96 2-s2.0-84873140820 10.1007/s10620-012-2327-9
9. Cao J., Zhang L., Huang S., Chen P., Zou L., Chen H., Xiang Y., Lai X., Ren G., Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in patients with chronic hepatitis B. Microbial Pathogenesis 2011 51 4 262 267 2-s2.0-79960928006 10.1016/j.micpath.2011.06.003
10. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nature Immunology 2009 10 1 29 37 2-s2.0-57849168934 10.1038/ni.1679
11. Wang X. F., Lei Y., Chen M., Chen C. B., Ren H., Shi T. D., PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication. Journal of Viral Hepatitis 2013 20 1 27 39 2-s2.0-84874595352 10.1111/jvh.12061
12. Zhuang H., Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chinese Medical Journal 2007 120 24 2159 2173 2-s2.0-38349116816
13. World Health Organization, Hepatitis B. 2012, World Health Organization Fact Sheet, http://www.who.int/mediacentre/factsheets/fs204/en
14. Barboza L., Salmen S., Peterson D. L., Montes H., Colmenares M., Hernández M., Berrueta-Carrillo L. E., Berrueta L., Altered T cell costimulation during chronic hepatitis B infection. Cellular Immunology 2009 257 1-2 61 68 2-s2.0-65049088229 10.1016/j.cellimm.2009.02.008
15. Sadra A., Cinek T., Arellano J. L., Shi J., Truitt K. E., Imboden J. B., Identification of tyrosine phosphorylation sites in the CD28 cytoplasmic domain and their role in the costimulation of Jurkat T cells. Journal of Immunology 1999 162 4 1966 1973 2-s2.0-0033558276 (Pubitemid 29288813)
16. - T cells in an autoimmune disease model. The Journal of Clinical Investigation 2003 112 7 1037 1048 2-s2.0-0242380323 10.1172/JCI200317935 (Pubitemid 38056319)
17. Webster G., Bertoletti A., Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection. Molecular Immunology 2001 38 6 467 473 2-s2.0-0035653974 10.1016/S0161-5890(01)00082-7 (Pubitemid 34008476)
18. - lymphocytes during aging. Experimental Gerontology 2004 39 4 539 544 2-s2.0-18744422561 10.1016/j.exger.2003.09.026 (Pubitemid 38402080)